obstructive sleep apnea-hypopnea syndrome, OSAHS
Conditions
Interventions
Experimental group:Deopioid analgesia
control group:nothing
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years old, gender is not limited; 2. OSA patients who chose UPPP; 3. It is rated I-III by the American Society of Aneshesiologists (ASA); 4. Volunteer to participate in the study and sign an informed consent;
Exclusion criteria
Exclusion criteria: 1. Those with a history of severe heart, lung and other systemic diseases; 2. Patients with severe liver, kidney and blood system dysfunction; 3. A history of gastrointestinal ulcers and drug or alcohol abuse; 4. Patients with a history of mental illness or preoperative cognitive; 5. Patients with a history of allergy to intraoperative drugs;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patient's 24h postoperative pain numerical analogue scale (NRS) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of adverse reactions such as respiratory depression, nausea and vomiting, lethargy, dizziness and fever within 48 hours after surgery;The ratio of troponin (CTnI) to troponin (CTnI) 48h after surgery and 24h before surgery;NRS scores were scored 12h, 36h, 48h after surgery;The number and dosage of remedial analgesic drugs during postoperative hospitalization;Incidence of chronic pain three months after surgery; | — |
Countries
China
Contacts
Public ContactShuhai Tang
Qilu Hospital of Shandong University
Outcome results
None listed